Shionogi (TSE:4507) Wins New Drug Approvals On Questions Over Whether The Value Case Still HoldsSimplywall·Sep 17 at 10:08 PM4507
Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.Unusual Whales·Sep 15 at 12:04 PMGSK-1.83%SGIOY-1.49%
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Grows By 797.8%Market Beat·Sep 11 at 01:20 AMSGIOY-1.49%4507
Shionogi presents new Phase 3 SCORPIO-PEP subpopulation data on COVID-19 antiviral XOCOVA at IDWeek 2026PUBT·Sep 9 at 12:31 PM4507
Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest UpdateMarket Beat·Aug 29 at 01:00 PMSGIOY-1.49%4507
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Decreases By 84.4%Market Beat·Aug 12 at 09:00 AMSGIOY-1.49%4507
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Increases By 279.3%Market Beat·Jul 26 at 02:20 PMSGIOY-1.49%4507
Shionogi (TSE:4507) Looks Cheap After FDA Accepts Cefiderocol Pediatric sNDASimplywall·Jul 20 at 01:13 PM4507
FDA accepts Shionogi sNDA for Fetroja pediatric use in serious Gram-negative infectionsPUBT·Jul 16 at 12:31 PMSGIOY-1.49%4507
